The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals - MarketLine Financial Deals

The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals

The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals - MarketLine Financial Deals
The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals
Published Nov 10, 2009
3 pages — Published Nov 10, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

The Westaim Corporation has entered into an agreement with Nucryst Pharmaceuticals Corp., a US-based developer and manufacturer of medical products focused on infection and inflammation, under which Westaim will acquire the remaining 25% outstanding stake in NUCRYST.

  
Source:
Document ID
MA12722_091113
Country
Country
Ticker
WED=CA
Ticker
NCST=US
Company
Nucryst Pharmaceuticals Corp
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals" Nov 10, 2009. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/The-Westaim-Corporation-to-acquire-remaining-25-outstanding-stake-in-Nucryst-Pharmaceuticals-2052-17596>
  
APA:
MarketLine Financial Deals. (2009). The Westaim Corporation to acquire remaining 25% outstanding stake in Nucryst Pharmaceuticals Nov 10, 2009. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/The-Westaim-Corporation-to-acquire-remaining-25-outstanding-stake-in-Nucryst-Pharmaceuticals-2052-17596>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.